Hainan Zhonghe Pharmaceutical Co.

PharmaceuticalsSeries CHaikou, Chinazhonghe.cn

Latest round

Series C

Last raised

Jan 2016

Total raised

$29M

Investors

2

About Hainan Zhonghe Pharmaceutical Co.

, Ltd. focuses on research, development, and manufacturing of peptide drugs in China and peptide bulk drug in Asia.

Who invested in Hainan Zhonghe Pharmaceutical Co.

2 investors across 2 rounds

See all investors in Hainan Zhonghe Pharmaceutical Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jan 1, 2016

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Sep 16, 2014

    Amount

    $29M

    Investors

    Locked

Questions about Hainan Zhonghe Pharmaceutical Co.

Who invested in Hainan Zhonghe Pharmaceutical Co.?

Hainan Zhonghe Pharmaceutical Co. has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Hainan Zhonghe Pharmaceutical Co. raised?

Hainan Zhonghe Pharmaceutical Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Hainan Zhonghe Pharmaceutical Co. last raise money?

Hainan Zhonghe Pharmaceutical Co.'s most recent round on record is a Series C, in Jan 2016.

What does Hainan Zhonghe Pharmaceutical Co. do?

Hainan Zhonghe Pharmaceutical Co. is a pharmaceuticals company.

Where is Hainan Zhonghe Pharmaceutical Co. headquartered?

Hainan Zhonghe Pharmaceutical Co. is headquartered in Haikou, China.

Which VCs invest in companies like Hainan Zhonghe Pharmaceutical Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Hainan Zhonghe Pharmaceutical Co.'s stage. Their profiles are linked below.

Raising like Hainan Zhonghe Pharmaceutical Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.